Opiant Pharmaceuticals (NASDAQ:OPNT) reported its Q4 earnings results on Tuesday, March 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Opiant Pharmaceuticals beat estimated earnings by 1200.0%, reporting an EPS of $0.11 versus an estimate of $-0.01.
Revenue was up $3.88 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.64 which was followed by a 9.78% drop in the share price the next day.
Here's a look at Opiant Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.08 | -0.71 | 0.07 | |
| EPS Actual | 0.56 | 0.31 | -0.66 | -0.16 |
| Revenue Estimate | 10.21M | 8.20M | 5.29M | 9.20M |
| Revenue Actual | 16.34M | 11.26M | 6.39M | 9.92M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
